Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results

Go back to Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results
(AMEX: IDXG) Delayed: 1.68 +0.05 (3.07%)
Previous Close $1.63    52 Week High $0.64 
Open $1.63    52 Week Low $0.10 
Day High $1.68    P/E N/A 
Day Low $1.63    EPS $0.00 
Volume 230